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WHAT IS THE VALUE OF SPECIALIST SHOULDER PHYSIOTHERAPY?  A COST-
UTILITY ANALYSIS 
 
We have evaluated the cost-effectiveness of specialist shoulder physiotherapy in 
routine practice. When commissioning health services, it is helpful to understand the 
costs and benefits associated with treatments. Well established generic measures 
such as the EuroQol (EQ-5D) can be used to estimate health-related quality of life 
(QALY) thus identifying the benefits of treatment derived by the patient. 
 
EQ-5D responses pre- & post-treatment were obtained from a sample of n=142 
patients undergoing routine physiotherapy treatment at a specialist Shoulder Unit 
over the period 2011-17. Patients were discharged from treatment when symptom-
free. Health-related utility scores were calculated using the UK tariff and QALYs were 
calculated by the area under the curve method (Manca 2005). Simplified treatment 
costs were calculated from the NHS perspective and assigned using event-weighted 
average of outpatient physiotherapy attendances reported in NHS Reference Costs 
2014-15. The comparator was no treatment, incurring zero treatment cost and no 
QALY gain assumed. 
 
In the sample: 69 male, 73 female; mean age 35.7 years (SD=18.9); duration of 
symptoms averaged 4.9 years; mean number of treatments 5 (max=20) over a period 
averaging 6.7 months (max=2.6 years). 76/142 had a prior course of physiotherapy 
for the same complaint. 59 had dominant arm problems, 20 were bilateral. There 
were 17 different diagnoses, with most patients having atraumatic glenohumeral 
instability or myofascial tightness of the upper quadrant. 
 
Treatment costs averaged £297 per patient (SD=186). Mean utility pre-treatment 
0.64 (SD=0.23) differed significantly the mean post-treatment 0.79 (SD=0.23) paired 
t=8.8 p<0.01. Incremental Cost-Effectiveness Ratio (ICER) £774 per QALY gain. 
 
NICE guidelines suggest that an ICER below £20000/QALY is indicative of cost 
effectiveness within the NHS. Subject to our assumptions, the results imply that 
specialist shoulder physiotherapy may provide the NHS with excellent value for 
money, even for patients with long-standing problems who have previously failed to 
benefit from physiotherapy. 
 
